The European Union may face a shortage of radioactive isotopes key to diagnosing a range of diseases and treating cancer, according to officials and documents. The EU is the world’s biggest producer of Molybdenum-99, a radio isotope used in 80% of all nuclear medicines procedures globally, including imaging scans to detect heart diseases and therapies to destroy cancer cells, EU data show.
Read more on CDE News